Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
408.28
-3.84 (-0.93%)
At close: Jun 27, 2025, 4:00 PM
407.95
-0.33 (-0.08%)
After-hours: Jun 27, 2025, 7:58 PM EDT
Thermo Fisher Revenue
Thermo Fisher had revenue of $10.36B in the quarter ending March 29, 2025, with 0.18% growth. This brings the company's revenue in the last twelve months to $42.90B, up 0.96% year-over-year. In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$42.90B
Revenue Growth
+0.96%
P/S Ratio
3.49
Revenue / Employee
$343,184
Employees
125,000
Market Cap
154.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
TMO News
- 2 days ago - Thermo Fisher Scientific Rises 3.1% After Key Trading Signal - Benzinga
- 4 days ago - Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies - Business Wire
- 5 days ago - Thermo Fisher Scientific Awarded $94.5 Million U.S. Government Contract to Supply the Navy with Advanced Radiation Detection Systems - Business Wire
- 8 days ago - Neurophotonics Research & Therapeutics Market 2025-2029: Global and Regional Analysis by Type and End User Featuring Carl Zeiss, Femtonics, Hitachi, Thermo Fisher Scientific and More - GlobeNewsWire
- 12 days ago - Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific's Accelerator™ Drug Development 360° CDMO and CRO Solutions - Business Wire
- 15 days ago - Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business - PYMNTS
- 15 days ago - Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms - Business Wire
- 15 days ago - Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports - Reuters